Biopharmaceuticals are medical drugs produced by application of genetic engineering and biotechnology methods. They are large biopolymers for therapeutic or in vivo diagnostic purposes, recommending a high demand of process control.
Because of the enormous number of large molecules with their inherent complexity, process development, optimization, and control are much more important than a patent molecule.
The key is the development of an engineering methodology based on standardized and well-characterized parts. “The consequences of synthetic biology will be as great as the development of chemical engineering from alchemy, with enormous and as perhaps unimaginable implications for medicine.” (Quelle: MIT)
The program combines essential engineering methods for process optimization and intensification with a state of the art laboratory work bench.